School of Medicine
Showing 1-8 of 8 Results
-
Jonathan Lavezo
Fellow in Pathology
Bio A native of Texas, Jonathan attended the University of North Texas in his hometown of Denton. After obtaining a double major in chemistry and biochemistry, he moved to the west Texas town of El Paso to attend the Paul L. Foster School of Medicine. Here is where he developed a deep interest in neuroendocrine disorders, in particular pituitary adenomas. He is currently an anatomic pathology resident at Stanford University and will begin his neuropathology fellowship starting in July of 2017.
-
Theresa Lii, M.D.
Fellow in Anesthesiology, Perioperative and Pain Medicine
Bio Theresa Lii, M.D., is currently a pain medicine fellow at Stanford and is part of the Stanford Fellowship in Anesthesia Research (FARM) program. Her research interests include evaluating the effectiveness of opioid-sparing pharmacologic treatments as well as exploring the impact of rapid-acting psychiatric interventions for patients with acute and chronic pain.
-
Adrienne H. Long, MD, PhD
Affiliate, Dean's Office Operations - Dean Other
Bio Adrienne H. Long, MD, PhD is a fellow in the Division of Pediatric Hematology and Oncology at the Lucile Packard Children's Hospital at Stanford. Dr. Long attend Northwestern University, where she earned both her BS in biomedical engineering and her MD. Determined to help develop novel treatments for pediatric cancer patients, she took time during medical school to pursue a PhD at the National Institutes of Health (NIH), where she helped advance CAR T cell therapies with Dr. Crystal Mackall. Her influential thesis work was the first to identify T cell exhaustion as a critical factor limiting efficacy of CAR therapies (Long et al., Nature Medicine, 2015), and also identified novel methods to enhance CAR therapies for pediatric solid tumor patients (Long/Highfill et al., Cancer Immunology Research, 2016). Dr. Long went on to complete her pediatrics residency training at Boston Children?s Hospital, where she continued her research in cancer immunology with Dr. Nicholas Haining ? this time focusing on strategies to enhance antigen presentation to augment checkpoint blockade (Long et al. Keystone Symposium on Cancer Immunotherapy, 2019). She remains dedicated to a career as a physician-scientist focused on developing novel immunotherapies for children with cancer.
